Mangoceuticals (MGRX) Total Liabilities (2022 - 2026)

Mangoceuticals has disclosed Total Liabilities across 5 years of filings, most recently posting $974571.0 for Q1 2026.

• Total Liabilities for Q1 2026 came in at $974571.0, down 35.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $974571.0 (down 35.17% YoY), and the FY2025 annual result was $890568.0, down 37.52% from the prior year.
• Total Liabilities came in at $974571.0 for Q1 2026 at Mangoceuticals, up from $890568.0 in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $1.6 million in Q2 2025 to a low of $240684.0 in Q3 2023.
• The 5-year median for Total Liabilities is $932569.5 (2025), against an average of $911916.1.
• Across the five-year window, Total Liabilities soared 483.15% in 2024 and slumped 42.7% in 2025, its largest moves.
• Mangoceuticals' Total Liabilities stood at $389257.0 in 2022, then declined by 29.09% to $276039.0 in 2023, then jumped by 416.4% to $1.4 million in 2024, then tumbled by 37.52% to $890568.0 in 2025, then rose by 9.43% to $974571.0 in 2026.
• The last three Total Liabilities figures came in at $974571.0 (Q1 2026), $890568.0 (Q4 2025), and $804275.0 (Q3 2025), per Business Quant data.